Antares Vision (AV) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
1 Nov, 2026Executive summary
FY 2023 revenue reached €213.9M, up 6.6% YoY and 6.4% organically; adjusted EBITDA fell to €13.3M from €17.9M as the business reorganized.
Results reflect a restatement of FY 2022 comparisons after audits found improperly recorded rfxcel L5 revenues in 2021–2023.
Management established four CGUs and a more detailed financial and operational reporting model; the new structure is intended to improve synergies, cost control and performance monitoring.
Financial highlights
Value of production was €226.2M, up 7.1%; cost of goods sold rose 5.0% to €55.9M, with its share of sales down 40 bps.
Adjusted EBITDA was €13.3M, down 25.6% YoY; adjusted EBITDA margin declined to 6.2% from 8.9%.
Adjusted EBIT was a loss of €2.8M versus €5.5M profit; net loss was €99.6M, while adjusted net loss was €8.1M versus €1.2M adjusted profit in FY 2022.
Labour costs increased 13.6% to €104.9M; reported financial component was negative €5.2M.
Outlook and guidance
The 2024–2026 plan prioritizes core-market growth, service expansion, inspection-machine focus in North America, faster standardized T&T products and new software use cases.
Margin and cash priorities include pricing optimization, lower external-service and purchasing costs, fixed-cost discipline, working-capital optimization and more balanced sales through the year.
Management expects to continue R&D and technology investment, expand recurring revenues and pursue integration, synergies and adjacent markets; assumptions use a prudent basis.
Presentation of the 2024–2026 Business Plan was scheduled for 18 June 2024.
Latest events from Antares Vision
- FY 2025 revenues fell 2% to €204M, with SCT and recurring revenue growth offsetting Life Science weakness.AV
Q4 2025 - 9M 2025 revenues up 5% to €134M; FY outlook flat with lower EBITDA margin expected.AV
Q3 2025 - Orders up 14%, revenues rose 3.3%, EBITDA doubled, and net loss narrowed in 1H 2025.AV
Q2 2025 - Margins and cash flow improved as orders rose and full-year guidance was confirmed.AV
Q3 2024 - Adjusted EBITDA turned positive at €3.4M as guidance is confirmed despite revenue decline.AV
Q2 2024 - 2024-2026 plan aims for strong revenue and EBITDA growth, driven by innovation and efficiency.AV
Strategy Update - Q1 2025 orders up 25% year-over-year, with recurring revenues at 49% of total.AV
Q1 2025 - Strong 4Q drives revenue, margin, and order growth, setting up a positive 2025 outlook.AV
Q4 2024 TU - Profitability and cash flow surged, with recurring revenues and leverage improving.AV
H2 2024